EEF2K expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.338400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.407000E-01
Normal-vs-Stage2
5.289800E-01
Normal-vs-Stage3
6.812100E-02
Normal-vs-Stage4
1.384200E-01
Stage1-vs-Stage2
7.471200E-01
Stage1-vs-Stage3
1.535790E-01
Stage1-vs-Stage4
4.333000E-01
Stage2-vs-Stage3
3.168400E-02
Stage2-vs-Stage4
1.166770E-01
Stage3-vs-Stage4
1.479530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.786400E-01
Normal-vs-AfricanAmerican
4.464200E-01
Normal-vs-Asian
2.523200E-01
Caucasian-vs-AfricanAmerican
2.951800E-01
Caucasian-vs-Asian
2.800800E-01
AfricanAmerican-vs-Asian
1.644580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.705600E-01
Normal-vs-Female
9.077800E-01
Male-vs-Female
8.197000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.998400E-01
Normal-vs-Age(41-60Yrs)
5.360800E-01
Normal-vs-Age(61-80Yrs)
7.536400E-01
Normal-vs-Age(81-100Yrs)
7.793400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.313000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.638600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.397600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.437800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.873800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.738800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.195800E-01
Normal-vs-Daily Drinker
6.462400E-01
Normal-vs-Weekly Drinker
7.404400E-01
Normal-vs-Occasional Drinker
7.816600E-01
Normal-vs-Social Drinker
7.918000E-01
Non Drinker-vs-Daily Drinker
9.180200E-01
Non Drinker-vs-Weekly Drinker
4.374000E-01
Non Drinker-vs-Occasional Drinker
4.506200E-01
Non Drinker-vs-Social Drinker
3.622600E-01
Daily Drinker-vs-Weekly Drinker
5.770000E-01
Daily Drinker-vs-Occasional Drinker
5.927400E-01
Daily Drinker-vs-Social Drinker
4.711800E-01
Weekly Drinker-vs-Occasional Drinker
9.401400E-01
Weekly Drinker-vs-Social Drinker
9.894800E-01
Occasional Drinker-vs-Social Drinker
9.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.256360E-01
Normal-vs-Grade 2
1.225540E-02
Normal-vs-Grade 3
1.466190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.794100E-02
Grade 1-vs-Grade 3
6.921600E-02
Grade 1-vs-Grade 4
1.256360E-01
Grade 2-vs-Grade 3
6.608800E-01
Grade 2-vs-Grade 4
1.225540E-02
Grade 3-vs-Grade 4
1.466190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.438600E-01
Normal-vs-NonDiabetic
9.336600E-01
Diabetic-vs-NonDiabetic
1.712830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.810600E-01
Normal-vs-NoPancreatitis
4.562200E-01
Pancreatitis-vs-NoPancreatitis
4.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.368600E-01
Normal-vs-N1
4.257400E-01
N0-vs-N1
2.051000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.182200E-01
Normal-vs-TP53-NonMutant
6.664800E-01
TP53-Mutant-vs-TP53-NonMutant
3.517000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
